KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Non-Current Debt: 2009-2024

Historic Non-Current Debt for Quest Diagnostics (DGX) over the last 16 years, with Dec 2024 value amounting to $5.6 billion.

  • Quest Diagnostics' Non-Current Debt fell 8.45% to $5.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $5.2 billion, marking a year-over-year decrease of 8.45%. This contributed to the annual value of $5.6 billion for FY2024, which is 27.32% up from last year.
  • Per Quest Diagnostics' latest filing, its Non-Current Debt stood at $5.6 billion for FY2024, which was up 27.32% from $4.4 billion recorded in FY2023.
  • Quest Diagnostics' 5-year Non-Current Debt high stood at $5.6 billion for FY2024, and its period low was $4.0 billion during FY2022.
  • Moreover, its 3-year median value for Non-Current Debt was $4.4 billion (2023), whereas its average is $4.7 billion.
  • Its Non-Current Debt has fluctuated over the past 5 years, first decreased by 0.80% in 2022, then rose by 27.32% in 2024.
  • Yearly analysis of 5 years shows Quest Diagnostics' Non-Current Debt stood at $4.0 billion in 2020, then declined by 0.07% to $4.0 billion in 2021, then decreased by 0.80% to $4.0 billion in 2022, then rose by 10.86% to $4.4 billion in 2023, then rose by 27.32% to $5.6 billion in 2024.